Multinational evidence-based recommendations for pain management by pharmacotherapy in inflammatory arthritis: integrating systematic literature research and expert opinion of a broad panel of rheumatologists in the 3e Initiative
Samuel Whittle(Queen Elizabeth Hospital), D. van der Heijde(Leiden University), René Westhovens(KU Leuven), Geraldo da Rocha Castelar Pinheiro(Universidade do Estado do Rio de Janeiro), Carlomaurizio Montecucco(University of Pavia), J.W. Bijlsma(Utrecht University), P Martínez-Osuna, Glen Hazlewood(University of Calgary), Rachelle Buchbinder(Institute for Musculoskeletal Health), Matthias Englbrecht(Friedrich-Alexander-Universität Erlangen-Nürnberg), Vivian P. Bykerk(Hospital for Special Surgery), Anca I. Catrina(Karolinska University Hospital), Pekka Hannonen(Central Finland Health Care District), Jaime Branco(Hospital de Egas Moniz), Jane Zochling(Royal North Shore Hospital), Jonathan L. Marks(University Hospital Southampton NHS Foundation Trust), Alexandra N. Colebatch(University Hospital Southampton NHS Foundation Trust), Daniel Aletaha(Medical University of Vienna), Claire Bombardier(Toronto General Hospital), Mikkel Østergaard(University of Copenhagen), Patrick Kiely(University of Limerick), Burkhard F. Leeb, Bethan Richards(Royal Prince Alfred Hospital), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), S. Ramiro(Amsterdam UMC Location University of Amsterdam), Ingo H. Tarner(Justus-Liebig-Universität Gießen), K. Adams(Université Laval), Ulf Müller‐Ladner(Justus-Liebig-Universität Gießen), Robert Landewé(Zuyderland Medisch Centrum), E. Lie(Diakonhjemmet Hospital), Helga Radner(Medical University of Vienna)
Cited by 94
Related Papers
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
|Arthritis & Rheumatism|1990|9.6k
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
|Arthritis & Rheumatism|2010|9.5k
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
|New England Journal of Medicine|2000|4k